# Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer

> **NCT00701870** · PHASE2 · TERMINATED · sponsor: **Telik** · enrollment: 1 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** ezatiostat hydrochloride (Telintra®)

## Key facts

- **NCT ID:** NCT00701870
- **Lead sponsor:** Telik
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study TLK199.2102 was terminated for lack of enrollment.
- **Last updated:** 2013-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701870, "Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00701870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*